1
, . 181: 252 (1997) LETTER TO THE EDITOR RT-PCR DETECTION OF CYTOKINE TRANSCRIPTS IN A SERIES OF CULTURED HUMAN MENINGIOMAS In a recent issue of the Journal of Pathology (Vol. 178, pp. 442–446, 1996), Boyle-Walsh et al. suggest that there are distinct patterns of cytokine mRNA expression linked to specific histological subtypes of meningioma. 1 They base this on an examination of 11 tumours, nine of which are described as classical and two atypical. They suggest that meningiomas are classified into three main groups: classic, angioblastic, and malignant. This was the case according to the 1979 WHO classifi- cation, 2 but an extensive revision was introduced in 1993. 3 The current classification recognizes benign, atypical, and malignant tumours, the most common benign subtypes being meningotheliomatous, transi- tional, and fibroblastic. It is now recognized that the angioblastic subtype is not a meningioma. The current AFIP Central Nervous System Tumour Fascicle, published in 1993, suggests that meningo- theliomatous, transitional, and fibroblastic meningiomas are a continuum rather than distinct entities, 4 and this would probably reflect the experience of most neuropathologists. Given this, it is surprising that dier- ent results were obtained for the dierent subtypes of tumour examined. S. F. D. R J. F. G Department of Morbid Anatomy St Bartholomew’s and The Royal London School of Medicine and Dentistry Whitechapel, London E1 1BB REFERENCES 1. Boyle-Walsh E, Birch M, Gallagher JA, et al. RT-PCR detection of cytokine transcripts in a series of cultured human meningiomas. J Pathol 1996; 178: 442–446. 2. Zülch KJ. Histological Typing of Tumours of the Central Nervous System. Geneva: World Health Organization, 1979. 3. Kleihaus P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System. 2nd edn. Berlin: Springer-Verlag, 1993. 4. Burger PC, Scheithauer BW. Tumors of the Central Nervous System. 3rd Series, Fascicle 10. Washington: Armed Forces Institute of Pathology, 1993. AUTHORS’ REPLY We thank Drs Robinson and Geddes for their interest and comments on our paper which detected dierent patterns of cytokine mRNA expression in histological subtypes of meningioma. 1 Their comments regarding classification of meningiomas reflect the recent changes which occurred during the time that our studies were performed. Meningiomas were kindly supplied to us by several neurosurgeons throughout the United Kingdom during 1991–1994 and the classification of the meningiomas was performed by the local neuropathologists. Since the majority of the specimens were obtained prior to publi- cation of the 1993 WHO classification, 2 they were classified according to the 1979 WHO guidelines. 3 As a result, the majority of meningiomas were either fibro- blastic, syncytial, or transitional, and a smaller number were atypical. Although the new classification and the AFIP Central Nervous System Fascicle 4 suggest that a continuum exists between the various meningiomas, the neuropathologists who reviewed the sections obviously recognized features that allowed them to subtype tumours according to the old WHO guidelines. Extraction and analysis of the mRNA were performed separately from the classification of the tumours and the results were matched up by an independent observer prior to final review. It is therefore very interesting, rather than surprising, that we have observed subtle dierences in cytokine mRNA in those meningiomas with features that allowed neuropathologists to classify them as syncytial, transitional, and fibroblastic. Perhaps those same histological features allowing the older classification are reflected in the altered cytokine profile observed. We have observed other dierences in staining pat- terns and cytokine excretion in cultured meningiomas that have been classified by the older guidelines (submit- ted for publication), which may also help to subclassify these benign tumours. E. B-W, M. B, J. A. G, V. S, A. S W. D. F Department of Clinical Chemistry Faculty of Medicine Royal Liverpool University Hospital Prescot Street, Liverpool L7 8XP, U.K. REFERENCES 1. Boyle-Walsh E, Birch M, Gallagher JA, et al. RT-PCR detection of cytokine transcripts in a series of cultured human meningiomas. J Pathol 1996; 178: 442–446. 2. Kleihaus P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System. 2nd edn. Berlin: Springer-Verlag, 1993. 3. Zülch KJ. Histological Typing of Tumours of the Central Nervous System. Geneva: World Health Organization, 1979. 4. Burger PC, Scheithauer BW. Tumours of the Central Nervous System. 3rd Series, Fascicle 10. Washington: Armed Forces Institute of Pathology, 1993.

LETTER TO THE EDITOR. RT-PCR detection of cytokine transcripts in a series of cultured human meningiomas

  • Upload
    j-f

  • View
    222

  • Download
    4

Embed Size (px)

Citation preview

Page 1: LETTER TO THE EDITOR. RT-PCR detection of cytokine transcripts in a series of cultured human meningiomas

, . 181: 252 (1997)

LETTER TO THE EDITOR

RT-PCR DETECTION OF CYTOKINE TRANSCRIPTS IN A SERIES OFCULTURED HUMAN MENINGIOMAS

In a recent issue of the Journal of Pathology (Vol. 178,pp. 442–446, 1996), Boyle-Walsh et al. suggest that thereare distinct patterns of cytokine mRNA expressionlinked to specific histological subtypes of meningioma.1They base this on an examination of 11 tumours, nine ofwhich are described as classical and two atypical.They suggest that meningiomas are classified into

three main groups: classic, angioblastic, and malignant.This was the case according to the 1979 WHO classifi-cation,2 but an extensive revision was introduced in1993.3 The current classification recognizes benign,atypical, and malignant tumours, the most commonbenign subtypes being meningotheliomatous, transi-tional, and fibroblastic. It is now recognized that theangioblastic subtype is not a meningioma.The current AFIP Central Nervous System Tumour

Fascicle, published in 1993, suggests that meningo-theliomatous, transitional, and fibroblastic meningiomasare a continuum rather than distinct entities,4 andthis would probably reflect the experience of most

neuropathologists. Given this, it is surprising that differ-ent results were obtained for the different subtypes oftumour examined.

S. F. D. R J. F. GDepartment of Morbid Anatomy

St Bartholomew’s andThe Royal London School of Medicine and Dentistry

Whitechapel, London E1 1BB

REFERENCES

1. Boyle-Walsh E, Birch M, Gallagher JA, et al. RT-PCR detection ofcytokine transcripts in a series of cultured human meningiomas. J Pathol1996; 178: 442–446.

2. Zülch KJ. Histological Typing of Tumours of the Central Nervous System.Geneva: World Health Organization, 1979.

3. Kleihaus P, Burger PC, Scheithauer BW. Histological Typing of Tumoursof the Central Nervous System. 2nd edn. Berlin: Springer-Verlag, 1993.

4. Burger PC, Scheithauer BW. Tumors of the Central Nervous System. 3rdSeries, Fascicle 10. Washington: Armed Forces Institute of Pathology, 1993.

AUTHORS’ REPLY

We thank Drs Robinson and Geddes for their interestand comments on our paper which detected differentpatterns of cytokine mRNA expression in histologicalsubtypes of meningioma.1 Their comments regardingclassification of meningiomas reflect the recent changeswhich occurred during the time that our studies wereperformed.Meningiomas were kindly supplied to us by several

neurosurgeons throughout the United Kingdom during1991–1994 and the classification of the meningiomas wasperformed by the local neuropathologists. Since themajority of the specimens were obtained prior to publi-cation of the 1993 WHO classification,2 they wereclassified according to the 1979 WHO guidelines.3 As aresult, the majority of meningiomas were either fibro-blastic, syncytial, or transitional, and a smaller numberwere atypical. Although the new classification and theAFIP Central Nervous System Fascicle4 suggest that acontinuum exists between the various meningiomas, theneuropathologists who reviewed the sections obviouslyrecognized features that allowed them to subtypetumours according to the old WHO guidelines.Extraction and analysis of the mRNA were performed

separately from the classification of the tumours and theresults were matched up by an independent observerprior to final review. It is therefore very interesting,rather than surprising, that we have observed subtle

differences in cytokine mRNA in those meningiomaswith features that allowed neuropathologists to classifythem as syncytial, transitional, and fibroblastic. Perhapsthose same histological features allowing the olderclassification are reflected in the altered cytokine profileobserved.We have observed other differences in staining pat-

terns and cytokine excretion in cultured meningiomasthat have been classified by the older guidelines (submit-ted for publication), which may also help to subclassifythese benign tumours.

E. B-W, M. B, J. A. G,V. S, A. S W. D. F

Department of Clinical ChemistryFaculty of Medicine

Royal Liverpool University HospitalPrescot Street, Liverpool L7 8XP, U.K.

REFERENCES1. Boyle-Walsh E, Birch M, Gallagher JA, et al. RT-PCR detection of

cytokine transcripts in a series of cultured human meningiomas. J Pathol1996; 178: 442–446.

2. Kleihaus P, Burger PC, Scheithauer BW. Histological Typing of Tumoursof the Central Nervous System. 2nd edn. Berlin: Springer-Verlag, 1993.

3. Zülch KJ. Histological Typing of Tumours of the Central Nervous System.Geneva: World Health Organization, 1979.

4. Burger PC, Scheithauer BW. Tumours of the Central Nervous System. 3rdSeries, Fascicle 10. Washington: Armed Forces Institute of Pathology, 1993.